Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma

This policy (A59412) is a response-to-comments notice related to MolDX LCD L39389 on molecular assays for diagnosing cutaneous melanoma and contains only comment and notice metadata (public comment period and effective/notice dates). It does not include clinical coverage criteria, limitations, frequency limits, or documentation requirements; consult LCD L39389 for the detailed, actionable coverage policy.

"This document is a 'Response to Comments' regarding MolDX Local Coverage Determination L39389 for molecular assays used in the diagnosis of cutaneous melanoma; it provides comment/notice metadata a..."

Sign up to see full coverage criteria, indications, and limitations.